Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumors
Austin J. Combest, Patrick J. Roberts, Patrick M. Dillon, Katie Sandison, Suzan K. Hanna, Charlene Ross, Sohrab Habibi, Beth Zamboni, Markus Müller, Martin Brunner, Norman E. Sharpless, William C. Zamboni
Dive into the research topics of 'Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumors'. Together they form a unique fingerprint.